Urologische Klinik und Poliklinik der Universität München
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Staehler, Michael
CARAT, NCT03374267: Registry Platform Urologic Cancer

Recruiting
N/A
1830
Europe
Routine care as per site standard.
iOMEDICO AG
Renal Cell Carcinoma, Urothelial Carcinoma
06/27
06/27
Casuscelli, Jozefina
ARASAFE, NCT05676203: A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

Recruiting
3
250
Europe
Standard ADT (androgen deprivation therapy), Standard Darolutamide, Docetaxel
Jena University Hospital, Bayer
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
07/25
01/27
P-EVOLUTION, NCT06657157: Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab As First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma

Recruiting
N/A
80
Europe
LMU Klinikum, Klinikum rechts der Isar, Technical University of Munich
Urothelial Cancer
07/26
10/26
Karpitschka, Martina
No trials found
Ingrisch, Michael
No trials found
Hellbach, Katharina
No trials found

Download Options